What is the cost effectiveness of specialist-led BNP guided therapy in patients over the age of 75 with CHF of any cause?
One cost-utility analysis found that specialist-led BNP guided therapy was cost effective (ICER: 8,123 per QALY gained) compared to specialist-led clinically-guided therapy in patients over the age of 75 with CHF of any cause. This was assessed as directly applicable with minor limitations.